Device companies join the train out of Andersen:
This article was originally published in Clinica
While citing no disagreement with the company, device manufacturers in increasing numbers have been reporting their exit from accounting company Arthur Andersen. Precise figures are not available, but the trend is up. Bard, Wright Medical, Exact Sciences and Bioject were among those last week deciding to transfer their business.
You may also be interested in...
Cilta-cel maintained high response rates in longer-term multiple myeloma data, but ide-cel causes less cytokine release syndrome and severe neurotoxicity – and it has a March decision date at the US FDA.
Our updated graphic tracker of key developments from the leading vaccine candidates.
Pathway open for drug as post-covalent BTK option as Loxo gears up for "risky" Phase III head-to-head study in Q1 2021.